相关实验视频
Updated: Jul 1, 2026

05:19
Surgical Models of Gastroesophageal Reflux with Mice
Published on: August 25, 2015
可溶性HLA-E和胃食道逆流性疾病:一种新的关联
Huda Saleem Hantoosh Hameed Al-Khalidy1, Wafaa Hazim Salih2, Batool Mutar Mahdi3
1Department of Biochemistry, Al-Kindy Medical College, University of Baghdad, Baghdad, Iraq.
Iranian journal of immunology : IJI
|March 27, 2025
概括
在患有胃食道逆流性疾病 (GERD) 的患者中,可溶性HLA-E (sHLA-E) 水平显著更高. 这一发现表明sHLA-E可能作为GERD诊断和理解其免疫病原发生的潜在生物标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 生物标志物发现发现
背景情况:
- 胃食道逆流性疾病 (GERD) 是一种广泛的胃肠道疾病,影响全球数百万人.
- 了解GERD的潜在免疫病原发生是制定有效的诊断和治疗策略的关键.
研究的目的:
- 研究可溶性HLA-E (sHLA-E) 作为GERD潜在生物标志物的作用.
- 评估sHLA-E水平与GERD的诊断和免疫病原发生之间的关联.
主要方法:
- 一项涉及40名GERD患者和40名健康对照者的病例控制研究.
- 血清sHLA-E水平使用三明治酶相关免疫吸收试验 (ELISA) 量化.
- 用接收器操作特征 (ROC) 曲线分析来评估诊断性能.
主要成果:
- 与健康对照组 (0.148 ng/mL) 相比,GERD患者的sHLA-E中位数 (0.370 ng/mL) 显著更高 (p = 0.021).
- 在预测GERD时,sHLA-E的ROC曲线下的面积 (AUC) 为0.649,表明中度的区分能力.
- 最佳切割值≤0.65 ng/mL显示了85.1%的灵敏度和27.3%的特异性.
结论:
- 血清sHLA-E水平升高与GERD有关.
- sHLA-E显示了作为GERD诊断的生物标志物的中等潜力.
- 需要进一步的研究来阐明sHLA-E在GERD免疫病原发生过程中的确切作用.
相关概念视频
Other Disorders of Digestive System
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Gastroesophageal Reflux Disease
Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...

